

Cogitum oral solution:
1 ampoule contains acetylaminosuccinate dipotassium salt (acetylamino-succinic acid) 250 mg;
Excipients: levulose, methyl parahydroxybenzoate, aromatic substances, distilled water;
10 ml in an ampoule of 30 pcs. packaged.
The active substance of the drug Cogitum - acetylamino-succinic acid is an endogenous biospecific compound contained in the central nervous system, especially in the brain. The drug helps to stabilize the processes of nervous regulation.
Functional asthenic conditions; neurosis with mild depression. The drug is used in the treatment of antidepressants as an adjuvant.
Hypersensitivity to the drug.
Cogitum appoint inside; the frequency of admission - 2 times a day.
500 mg (2 amp.) Are taken in the morning and 250 mg (1 amp.) - at night.
Maximum daily dose not determined. The average duration of treatment is 3 weeks.
The drug can be diluted with a small amount of water or taken undiluted.
Possible: hypersensitivity reactions to the components of the drug.
When using the drug during periods of pregnancy and lactation, there were no cases of its negative impact.
The drug can be prescribed to children and elderly people.
It is possible to change the dosing regimen in accordance with the recommendations of the attending physician.
The drug should be stored in a dark place at room temperature.
Coagitum oral